CN112725288A - 犬腺病毒2型弱毒疫苗株及其应用 - Google Patents
犬腺病毒2型弱毒疫苗株及其应用 Download PDFInfo
- Publication number
- CN112725288A CN112725288A CN202110057376.6A CN202110057376A CN112725288A CN 112725288 A CN112725288 A CN 112725288A CN 202110057376 A CN202110057376 A CN 202110057376A CN 112725288 A CN112725288 A CN 112725288A
- Authority
- CN
- China
- Prior art keywords
- adenovirus type
- canine
- virus
- canine adenovirus
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110057376.6A CN112725288B (zh) | 2021-01-15 | 2021-01-15 | 犬腺病毒2型弱毒疫苗株及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110057376.6A CN112725288B (zh) | 2021-01-15 | 2021-01-15 | 犬腺病毒2型弱毒疫苗株及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112725288A true CN112725288A (zh) | 2021-04-30 |
CN112725288B CN112725288B (zh) | 2022-07-26 |
Family
ID=75591781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110057376.6A Active CN112725288B (zh) | 2021-01-15 | 2021-01-15 | 犬腺病毒2型弱毒疫苗株及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112725288B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6156567A (en) * | 1996-07-03 | 2000-12-05 | Merial | Truncated transcriptionally active cytomegalovirus promoters |
CN1718242A (zh) * | 2004-07-07 | 2006-01-11 | 中国人民解放军军事医学科学院军事兽医研究所 | 狂犬病病毒糖/核等结构蛋白的犬2型腺病毒重组疫苗 |
CN101905021A (zh) * | 2010-07-30 | 2010-12-08 | 中国农业科学院哈尔滨兽医研究所 | 犬瘟热、犬细小病毒和犬腺病毒i型三联活疫苗及其制备方法 |
CN101914502A (zh) * | 2010-07-30 | 2010-12-15 | 中国农业科学院哈尔滨兽医研究所 | Ⅰ型犬腺病毒弱毒疫苗株及其应用 |
CN108342362A (zh) * | 2018-01-31 | 2018-07-31 | 武汉枢密脑科学技术有限公司 | 一种用于扩增重组犬腺病毒cav2的稳定细胞系mdck及其构建方法 |
-
2021
- 2021-01-15 CN CN202110057376.6A patent/CN112725288B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6156567A (en) * | 1996-07-03 | 2000-12-05 | Merial | Truncated transcriptionally active cytomegalovirus promoters |
CN1718242A (zh) * | 2004-07-07 | 2006-01-11 | 中国人民解放军军事医学科学院军事兽医研究所 | 狂犬病病毒糖/核等结构蛋白的犬2型腺病毒重组疫苗 |
CN101905021A (zh) * | 2010-07-30 | 2010-12-08 | 中国农业科学院哈尔滨兽医研究所 | 犬瘟热、犬细小病毒和犬腺病毒i型三联活疫苗及其制备方法 |
CN101914502A (zh) * | 2010-07-30 | 2010-12-15 | 中国农业科学院哈尔滨兽医研究所 | Ⅰ型犬腺病毒弱毒疫苗株及其应用 |
CN108342362A (zh) * | 2018-01-31 | 2018-07-31 | 武汉枢密脑科学技术有限公司 | 一种用于扩增重组犬腺病毒cav2的稳定细胞系mdck及其构建方法 |
Non-Patent Citations (2)
Title |
---|
R CURTIS 等: "The pathogenicity of an attenuated strain of canine adenovirus type 2 (CAV-2)", 《VET REC》 * |
李六金等: "犬腺病毒Ⅱ型弱毒疫苗株的分离、鉴定与筛选", 《青海科技》 * |
Also Published As
Publication number | Publication date |
---|---|
CN112725288B (zh) | 2022-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103849632B (zh) | 鸡传染性支气管炎弱毒株s1基因及其弱毒株和应用 | |
CN113337478B (zh) | 一株猫细小病毒毒株及其应用 | |
CN106947746B (zh) | 鸡传染性支气管炎致弱疫苗株ldl-t株及其应用 | |
CN109868262B (zh) | 一种犬瘟热弱毒株及其应用 | |
CN110643632B (zh) | 一种基于甲病毒复制子载体的狂犬病毒感染性克隆及制备方法和应用 | |
CN113564130B (zh) | 柯萨奇病毒a10型毒株及其应用 | |
CN104130982A (zh) | 一种重组伪狂犬病病毒及其构建方法和应用 | |
CN111748529A (zh) | 猪伪狂犬病病毒毒株及其应用 | |
CN114561366B (zh) | 一种山羊库布病毒分离株及其应用 | |
CN114426956B (zh) | 猫狂犬病泛白细胞减少症鼻气管炎鼻结膜炎四联灭活疫苗 | |
CN111635890A (zh) | 一株犬细小病毒new CPV-2b毒株及其应用 | |
CN111073862B (zh) | 一种牛病毒性腹泻2型减毒毒株及应用 | |
CN106854647B (zh) | 鸭病毒性肝炎二价蛋黄抗体及其制备方法和应用 | |
CN109735504B (zh) | 犬瘟热病毒弱毒疫苗株及其应用 | |
CN108949700B (zh) | 一种山羊副流感病毒3型js14-2株及其应用 | |
CN112725288B (zh) | 犬腺病毒2型弱毒疫苗株及其应用 | |
CN113564132B (zh) | 柯萨奇病毒a16型毒株及其应用 | |
CN114921422A (zh) | 一种犬源猫细小病毒分离株及其应用 | |
CN116121202A (zh) | 一种柯萨奇病毒b组1型毒株及应用 | |
CN112899240B (zh) | 犬副流感病毒弱毒株、其应用及疫苗 | |
CN111097044A (zh) | 犬型钩端螺旋体、黄疸出血型钩端螺旋体、犬冠状病毒三联灭活疫苗 | |
CN111494614A (zh) | 一种三联灭活疫苗及其制备方法 | |
RU2631925C2 (ru) | Штамм "Шевченко-2014" вируса геморрагической болезни кроликов для изготовления вакцинных, диагностических и лечебных препаратов | |
CN108130315B (zh) | H3n2亚型猪流感病毒细胞适应株及其制备的灭活疫苗和应用 | |
RU2416642C1 (ru) | Штамм "манихино-09" вируса геморрагической болезни кроликов для изготовления вакцинных и диагностических препаратов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Jin Kuoshi Inventor after: Zhao Zhuo Inventor after: Wang Li Inventor after: Jiang Housheng Inventor after: Xue Xinghua Inventor after: Han Junguo Inventor after: He Yaqi Inventor after: Hu Yibin Inventor after: Li Xiaoliang Inventor after: Li Sanpeng Inventor after: Shang Chuanchuan Inventor after: Shang Yunpeng Inventor before: Jin Kuoshi Inventor before: Wang Li Inventor before: Jiang Housheng Inventor before: Han Junguo Inventor before: He Yaqi Inventor before: Hu Yibin Inventor before: Li Xiaoliang Inventor before: Li Sanpeng Inventor before: Shang Chuanchuan Inventor before: Shang Yunpeng Inventor before: Zhao Zhuo |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |